138 related articles for article (PubMed ID: 8219241)
1. Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission.
Snyder DS; Chao NJ; Amylon MD; Taguchi J; Long GD; Negrin RS; Nademanee AP; O'Donnell MR; Schmidt GM; Stein AS
Blood; 1993 Nov; 82(9):2920-8. PubMed ID: 8219241
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience.
Jamieson CH; Amylon MD; Wong RM; Blume KG
Exp Hematol; 2003 Oct; 31(10):981-6. PubMed ID: 14550815
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study.
Blume KG; Kopecky KJ; Henslee-Downey JP; Forman SJ; Stiff PJ; LeMaistre CF; Appelbaum FR
Blood; 1993 Apr; 81(8):2187-93. PubMed ID: 8471778
[TBL] [Abstract][Full Text] [Related]
5. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
[TBL] [Abstract][Full Text] [Related]
6. Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
Snyder DS; Negrin RS; O'Donnell MR; Chao NJ; Amylon MD; Long GD; Nademanee AP; Stein AS; Parker PM; Smith EP
Blood; 1994 Sep; 84(5):1672-9. PubMed ID: 8068956
[TBL] [Abstract][Full Text] [Related]
7. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
[TBL] [Abstract][Full Text] [Related]
9. Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias.
Schmitz N; Gassmann W; Rister M; Johannson W; Suttorp M; Brix F; Holthuis JJ; Heit W; Hertenstein B; Schaub J
Blood; 1988 Nov; 72(5):1567-73. PubMed ID: 3052626
[TBL] [Abstract][Full Text] [Related]
10. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.
Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
Leuk Lymphoma; 1996 Jul; 22(3-4):271-7. PubMed ID: 8819076
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.
Brochstein JA; Kernan NA; Groshen S; Cirrincione C; Shank B; Emanuel D; Laver J; O'Reilly RJ
N Engl J Med; 1987 Dec; 317(26):1618-24. PubMed ID: 3317056
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
[TBL] [Abstract][Full Text] [Related]
13. Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings.
Zecca M; Pession A; Messina C; Bonetti F; Favre C; Prete A; Cesaro S; Porta F; Mazzarino I; Giorgiani G; Rondelli R; Locatelli F
J Clin Oncol; 1999 Jun; 17(6):1838-46. PubMed ID: 10561223
[TBL] [Abstract][Full Text] [Related]
14. [Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
Schmitz N; Kayser W; Gassmann W; Euler HH; Wüstemann M; Brix F; Dühmke E; Hebbinghaus D; Gremmel H; Schaub J
Dtsch Med Wochenschr; 1985 Sep; 110(39):1488-93. PubMed ID: 3896727
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Dopfer R; Henze G; Bender-Götze C; Ebell W; Ehninger G; Friedrich W; Gadner H; Klingebiel T; Peters C; Riehm H
Blood; 1991 Nov; 78(10):2780-4. PubMed ID: 1824271
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
Fyles GM; Messner HA; Lockwood G; Curtis JE; Rider W; Minden MD; Meharchand JM; Lipton J; Tritchler D; Van Dyk J
Bone Marrow Transplant; 1991 Dec; 8(6):453-63. PubMed ID: 1790425
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission.
Blume KG; Forman SJ; Snyder DS; Nademanee AP; O'Donnell MR; Fahey JL; Krance RA; Sniecinski IJ; Stock AD; Findley DO
Transplantation; 1987 Mar; 43(3):389-92. PubMed ID: 3547796
[TBL] [Abstract][Full Text] [Related]
19. Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.
Emminger W; Emminger-Schmidmeier W; Haas OA; Urban C; Ambros P; Peters C; Mann G; Fink FM; Ferstl G; Höcker P
Bone Marrow Transplant; 1992 May; 9(5):313-8. PubMed ID: 1617314
[TBL] [Abstract][Full Text] [Related]
20. Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.
Laport GG; Alvarnas JC; Palmer JM; Snyder DS; Slovak ML; Cherry AM; Wong RM; Negrin RS; Blume KG; Forman SJ
Blood; 2008 Aug; 112(3):903-9. PubMed ID: 18519812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]